LifeAssays AB (publ) Stock

LifeAssays publ AB is a Sweden-based diagnostic company. It is engaged in the provision of in-house diagnostic testing for community health centers and physicians, as well as for home use and veterinary applications. The Company develops and markets point-of-care testing (POCT) instruments and technology for the diagnosis of diabetes, renal dysfunction and cardiovascular diseases. The Company's business portfolio comprises such products, as LifeAssays Canine CRP Test Kit, which monitors inflammation in dogs for early disease intervention; LifeAssays CRP Test Kit, which is a reagent kit for high-sensitive C-Reactive Protein (hsCRP) and normal range C-Reactive Protein (CRP) in whole blood; LifeAssays Reader, which utilizes a disposable algorithm chip containing all reagent identification data, as well as, a self-executable algorithm; and LifeAssays Vet Reader, which offers veterinary practitioners all the functions provided with the LifeAssays Reader.